Annual General Meeting 2024


June 24, 2024

Amsterdam

Past events

Kempen Life Sciences Conference 2021


April 28, 2021

Virtual Event

Fourth Quarter and Full-Year 2020 Financial Results and Business Updates – Conference Call & Webcast


April 15, 2021

CureVac N.V. (Nasdaq: CVAC) reported financial results and business updates for the fourth quarter and full-year of 2020 on Thursday, April 15, 2021, at 4:00 p.m. CET / 10:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript as well as the archived webcast below.

Credit Suisse 2021 London Global Healthcare Conference


March 2, 2021

Virtual Event
Fireside Chat: 12:00 p.m. GMT / 7:00 a.m. EST

Leerink 10th Annual Global Healthcare Conference


February 24, 2021

Virtual Event
Presentation: 8:00 a.m. EST

Downloads

Management attending JP Morgan 39th Annual Healthcare Conference


January 11 - 14, 2021

For meeting inquiries please contact investors@curevac.com.

Berenberg European Conference 2020


December 2, 2020

Online

Third Quarter and First 9 Months 2020 Financial Results and Business Updates – Conference Call & Webcast


November 30, 2020

CureVac N.V. (Nasdaq: CVAC) announced financial results and business updates for the third quarter and first nine months of 2020 on Monday, November 30, 2020. The company hosted a conference call and webcast on the same day at 4:00 p.m. CET / 10:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript and archived webcast below.

Positive Interim Phase 1 Data of CureVac’s COVID-19 Vaccine Candidate, CVnCoV – Conference Call & Webcast


November 10, 2020

The press release, presentation and transcript can be downloaded below, the archived webcast is available through the following link.

ACT 2020 Annual Meeting


November 15–18, 2020

Austin, Texas, USA

Berenberg US CEO Conference 2020


November 13, 2020

Online

SITC 2020


November 10–14, 2020

Online

8th International mRNA Health Conference


November 9–10, 2020

Online

ESMO Congress 2020


September 18–22, 2020

Madrid, Spain

CICON 2020


September 14–17, 2020

New York, USA

Conference Call “Strategic Partnerships to Deliver CureVac’s COVID-19 Ambition”


February 5, 2021

CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), hosted a conference call and webcast on Friday February 5, 2021 at 4:00 p.m. CET / 10:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript and archived webcast below.